<DOC>
	<DOCNO>NCT01025843</DOCNO>
	<brief_summary>This two part introductory clinical trial MK-5478 . Part I evaluate safety , tolerability pharmacokinetics pharmacodynamics MK-5478 young , healthy male . Part II evaluate safety , tolerability pharmacodynamic effect MK-5478 participant hypertension . The primary hypothesis single oral dos MK-5478 sufficiently safe well tolerate .</brief_summary>
	<brief_title>Safety Tolerability MK-5478 Participants With Hypertension ( 5478-001 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Part I : Is male 18 50 year age Is good health Is nonsmoker Part II : Is male nonchild bear potential 18 50 year age Has hypertension ( high blood pressure ) Part I Part II : Has history stroke , seizures major neurological disorder Has history cancer Has history cardiovascular disease Is unable refrain use prescription nonprescription drug Consumes excessive amount alcohol caffeine Has major surgery , donate blood participate another investigational study past 4 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>